I'll qualify it by saying I'm not the best person to answer that. The people who are closest to it and in day-to-day contact with patients will be best able to inform you. They include a combination of nuclear medicine specialists and those in other associated specialties, like cardiology. So a cardiologist or a group of cardiologists is well equipped to tell you the impact on their patients of being offered alternatives. There might be no change in the schedule, but they may receive a different product that might give a different thing. But a cardiologist would be best.
Oncologists and the cancer community are well equipped to tell you the impact it has on cancer patients. I checked with colleagues across the country within the Canadian Cancer Society and the cancer agencies. The many steps that have been taken by all people in the supply chain, including the front-line specialists, are minimizing the impact on patients to this point. Some rescheduling is going on, particularly last week. There appear to be a minimum number of cancellations. It is troubling and disturbing for any patient who thinks they're coming for a procedure at this time to have it rescheduled and pushed back. But the information I'm getting through the cancer community is that the steps everybody else is taking are, to the largest extent possible, protecting patients' interests at this point.